Zhejiang Weixin Biological Products

Zhejiang Weixin Biological Products is a Chinese biopharmaceutical company primarily focused on the research, development, and commercialization of human vaccines. Located in Huzhou, Zhejiang, the company operates a large-scale manufacturing facility dedicated to producing the Rabies Vaccine (Vero Cell), which is its flagship product. In 2012, the company was acquired by Liaoning Cheng Da Biotechnology (Chengda Bio), a major player in the global rabies vaccine market. As a subsidiary, Zhejiang Weixin contributes to the parent company's production capacity and helps maintain its leadership position in the Chinese vaccine industry. The company's facilities are compliant with national Good Manufacturing Practice (GMP) standards.